1/159
Looks like no tags are added yet.
Homicidal poisoning
the killing of a human being by the administration of poison
fulminant poisoning
Owing to the massive dose, death precedes very rapidly without any onset of symptoms
Toxic Syndrome
Cholinergic Syndrome
Anticholinergic Syndrome
Sympathomimetic Syndrome
Sedative/Hypnotic Syndrome
On the basis of duration of exposure, sign and symptoms, medical practitioner can categorize the poisoning in
fulminate, acute, sub-acute, chronic and sub chronic
Vital Signs
associated with the overdosed cases, cardiac arrhythmias, respiratory/ cardiovascular depression, and impairment of consciousness, convulsions agitation, and muscular weakness
Postmortem redistribution (PMR)
• Drug movements within the body after death.
• This cause time- dependent variations in blood and tissue drug concentrations prior to autopsy
Major contributing elements to PMR
•Drug Chemistry
•Drug Pharmacokinetics
•Distribution Mechanisms
Drug Chemistry
• Acid / Base Properties (pKa)
• Lipophilicity
• Size and Structure
pKa?
It is derived from Ka which is the equilibrium constant for the chemical reaction known as dissociation in the context of acid-base reactions
pKa = - log10Ka
the smaller the pKa the stronger the acid
the higher the pKa, the stronger the base
• Thus one can determine the degree of ionization at a given pH
Normal biological pH
7.4
When we substitute these elements (pH and pKa) in to the Henderson-Hasselbalch equation
we can mathematically determine how much of a drug is ionized at a biological pH
pH = pKa + log([conjugate base]/[conjugate acid])
pOH = pKa + log([conjugate base]/[conjugate acid])
Lipophilicity
the ability of a chemical compound (lipophilic) to dissolve in fats, oils, lipids, and non-polar solvents such as hexane or toluene.
hydrophilic ("water-loving") substances
tend to dissolve in water
The nonionized form of the drug
tends to be more lipid soluble=more lipophilic
Drug Chemistry effects drugs ability to
bind with plasma proteins and tissues in the blood
Volume of Distribution (Vd)
pharmacokinetic parameter representing an individual drug’s propensity to either remain in the plasma or redistribute to other tissue compartments.
Vd is a proportionality constant that relates the total amount of drug in the body to the plasma concentration of the drug at a given time.
meaning that a higher dose of a drug is required to achieve a given plasma concentration
Cell Death
- Aerobic respiration stops
- Oxygen is no longer provided (hypoxia)
- In the mitochondria, oxygen was the final electron receptor of the electron transport system responsible for the synthesis of ATP from NADH
• Thus we no longer have ATP to run cellular operations - and cellular death begins
Build up of lactic acid
result in decreases in intercellular pH
Lysosomal enzymes
leak out and become active
Distribution Mechanism
“Micro” Redistribution
Acidification
Passive Diffusion
Blood Coagulation and Hypostasis
Postmortem “Circulation”
Putrefaction
Micro Redistribution
• Enzymes, proteases, phosphatases, glucosidases all leak into the cytoplasm - further breaking down cellular components
• Macromolecules, proteins, and the drugs bound to them (or detached) drift out into the extracellular space
• This tends to be higher in tissues rich in enzymes (pancreas and gastric mucosa) and slower in the heart, liver, and kidney
Acidification
Contents of a cell become more acidified after death
• After a cell lyses, progressively ionized drugs will distribute more readily as a result of being transported in the acidic fluid in which they are dissolved
Redistribution
blood and tissue
Passive Diffusion
Organs which are close to the heart and major blood vessels
temp and concentration can effect this
Blood Coagulation and Hypostasis (Livor)
• Blood sediments and clots unevenly after death
• This is due to blood clotting and cell lysis happening simultaneously
• As hours pass, hypostasis occurs when the blood sediments and serum flow, according to gravity, to the lower parts of the body
• Drugs follow according to their respective chemistries
Body Position
• It’s been demonstrated that body position may influence PMR
Putrefaction
Decomposition of organic matter by bacterial or fungal digestion, which causes the release of gases that infiltrate the body's tissues and leads to the deterioration of the tissues and organs.
Enteric bacteria
can metabolize drugs and produce ethanol
Postmortem circulation
• Rigor mortis can cause blood movement by causing systolic pressure through ventricular contractions
• Putrefactive processes in the abdomen can move blood due to gas swelling
Environmental Conditions
• Storing decedents between 2 – 8oC prior to autopsy
-Slows redistribution
-Slows putrefaction
• Conversely, warmer temperatures have the opposite effect
Autopsy specimens
• Central Blood (#1 Heart, #2 Subclavian artery)
• Peripheral Blood (#3 Inferior Vena Cava)
• Vitreous Humor
• Tissue (Liver, Brain)
Testing alternative tissues
• Lung
• Cerebrospinal fluid
• Bone Marrow
• Skeletal Muscle
Drug distribution
the disbursement of an unmetabolized drug as it moves through the body’s blood and tissues
the brain and testes are unique
lipophilic or hydrophilic
Based on lipid and non-lipid solubility, drugs can be classified as
Lipophiliic (Fat Soluble)
• Biotransformed in the liver
• Excreted through the bile duct
Hydrophilic (Water Soluble)
• Eliminated by kidneys
Pervitin. aka “Piko”
Germany marketed methamphetamine tablets
2010s–Present
While public and regulatory attention shifted toward prescription opioids, illicit methamphetamine trafficking, high-purity crystal meth, and liquid methamphetamine concealment by transnational cartels continued to rise nationwide, accompanied by increasing stimulant-related overdose trends.
Xylazine
a non-opioid veterinary tranquilizer, muscle relaxant, and central nervous system depressant.
drug
a natural or synthetic substance used to produce physiological or psychological effects
Narcotic drugs
(analgesics) relieve pain by depressing the CNS, affecting blood pressure, pulse, and breathing
Opiate
a drug derived from the opium poppy (morphine, codeine); excludes synthetics
Opioid
any substance with morphine-like activity: natural, semi-synthetic, and synthetic (includes fentanyl)
Narcotic
an obsolete, loosely used legal/media term for drugs of abuse; avoid it scientifically
Addiction
Psychological dependence with compulsive use and craving, continuing despite harm.
Tolerance
Higher doses needed over time to produce the same effect.
Dependence
Sudden absence produces a physical withdrawal syndrome.
Withdrawal
Cluster of physiological signs/symptoms after abruptly stopping a drug
Physical addiction
(alcohol, opioids, depressants) causes withdrawal sickness
psychological addiction
(cocaine, PCP) is driven by dopamine reward
schedule i
High abuse; no accepted medical use
Heroin, LSD, MDMA, psilocybin, most marijuana*
schedule ii
High abuse; accepted use, severe dependence
Cocaine, methamphetamine, fentanyl, oxycodone, morphine
schedule iii
Moderate/low dependence; accepted use
Ketamine, buprenorphine, anabolic steroids, medical marijuana*
schedule iv
Low abuse vs III
Diazepam, alprazolam, zolpidem, tramadol
schedule v
Lowest abuse; limited narcotics
Limited-codeine cough preps, pregabalin
In April 2026 the DEA moved FDA-approved and state-licensed medical marijuana to
Schedule III; broader rescheduling was still pending. Schedules are a legal, not pharmacological, classification — verify current status.
Stimulants
Increase alertness and energy
Cocaine, methamphetamine, MDMA
Opioids
Pain relief, sedation, respiratory depression
Heroin, oxycodone, fentanyl
Depressants
Slow CNS activity
Benzodiazepines, barbiturates, GHB
Hallucinogens / dissociatives
Alter perception, mood, cognition
LSD, psilocybin, PCP, ketamine
Cannabinoids
Euphoria and altered perception
Marijuana, hashish, synthetic cannabinoids
NPS
Mimic or evade controlled drugs
Cathinones, nitazenes, designer benzos
The analytical workflow
Receive & characterize → Analyze → Report & testify
Document and weigh first; sample representatively. Run presumptive tests, then confirm identity with at least two uncorrelated techniques. The deliverable is a defensiblereport and expert testimony, with chain of custody intact.
category a
Structural
MS (GC-MS, LC-MS), FTIR, Raman, NMR
category b
Moderate
TLC, GC, LC, ion mobility, melting point
category c
Screening
Color tests, immunoassay, UV/fluorescence
SWGDRUG rule
with a Category-A technique, add at least one more; without one, use ≥3 validated methods, two of them uncorrelated Category B. No single weak test is specific — presumptive narrows, confirmation identifies.
Marquis
Formaldehyde / H₂SO₄
Opiates purple; amphetamines orange-brown; MDMA purple-black
Scott
Cobalt(II) thiocyanate
Cocaine blue
Simon's
Nitroprusside / acetaldehyde
Secondary amines (methamphetamine) blue
Duquenois–Levine
Vanillin/acetaldehyde, HCl, chloroform
Cannabis purple in chloroform layer
Mecke
Vanillin/acetaldehyde, HCl, chloroform
Heroin green to blue-green
Ehrlich
p-DMAB in acid
LSD and other indoles purple
Heroin
6-MAM (specific marker) → morphine
Cocaine
Benzoylecgonine; cocaethylene only with alcohol
Cannabis (THC)
THC-COOH in urine (past use); THC in blood (recent)
Methamphetamine
Amphetamine (active metabolite)
Codeine
Morphine (via CYP2D6 O-demethylation — a prodrug)
Fentanyl
Norfentanyl in urine
Toxicology path
screen (immunoassay) → confirm (LC-MS/MS or GC-MS) → interpret parent vs metabolite, timing, and matrix.
pKa = −log₁₀ Ka.
The smaller the pKa the stronger the acid; the higher the pKa the stronger the base. pKa lets you find the degree of ionization of a drug at a given pH.
At biological pH ≈ 7.4
the ionization state governs absorption and distribution. The non-ionized form is more lipid-soluble (more lipophilic) and crosses membranes more readily — the key to where a drug goes.
Lipophilicity
ability to dissolve in fats/non-polar solvents; non-ionized drug is more lipophilic and better distributed
Protein binding
albumin binds acidic drugs; α₁-acid glycoprotein binds basic drugs; only free drug is active.
Volume of distribution (Vd)
high Vd means the drug leaves plasma for tissues (imipramine 20–40 L/kg); low Vd stays in plasma (ethanol <1 L/kg).
Size & structure and storage depots
(fat, bone) further shape distribution.
Stimulants Mechanism
raise dopamine, norepinephrine, and serotonin signaling; cocaine blocks reuptake, amphetamines and cathinones force release.
Forensic Stimulants
cocaineScott test (cocaine blue), Simon's (methamphetamine), benzoylecgonine and cocaethylene markers
Opioids — the poppy and the receptors
Opioids bind μ, δ, and κ receptors in the CNS and periphery.
The μ receptor drives the key effects: μ₁ = analgesia; μ₂ = respiratory and cardiovascular depression, sedation, euphoria, GI slowing, urinary retention — no μ₁-selective opioid exists. Opioids were ranked the most addictive drug class.
Opioids Signs
pinpoint pupils (miosis),
Morphine
Natural
Pure μ agonist; metabolites M3G, M6G
Codeine
Natural
Prodrug → morphine (CYP2D6); 7–10% are poor converters
Heroin
Semi-synthetic
Diacetylmorphine → 6-MAM → morphine
Oxycodone / hydrocodone
Semi-synthetic
Prescription; often counterfeited
Fentanyl
Synthetic
μ agonist; 50–100× morphine; no metabolites
Methadone
Synthetic
Long-acting; neuropathic pain; no metabolites
Tramadol
Atypical
Opioid + noradrenaline/serotonin; active M1
Fentanyl and its analogues — potency
Fentanyl is a synthetic piperidine μ agonist, 50–100× morphine, structurally like pethidine. 'Fentanyl' is a family — changing substituents on the core creates analogues with different potency and duration
Naloxone (Narcan)
pure opioid antagonist that displaces opioids from receptors, acting 30–60 min — it may wear off before a long-acting opioid, and does not work on non-opioid overdose.